Wolfram Samlowski is a medical oncologist with Comprehensive Cancer Centers of Nevada (CCCN) and a member of the Research Developmental Therapeutics and Genitourinary Committees for US Oncology.
His research interests include translational research and development of novel cancer immunotherapy agents, translational drug development as well as gene therapy.
His clinical interests are in developing more effective treatments for advanced stages of melanoma and non-melanoma skin cancers (such as Merkel Cell Carcinoma), and renal cancer.